Novo Nordisk has started building its first brand ... Reimagining What's Possibl In a new white paper from the World Without Disease initiative, a 2024 update is provided of the current endeavours ...

A clinical trial has backed the safety and efficacy of one of Novo Nordisk's weight-loss medicines ... Reimagining What's Possibl In a new white paper from the World Without Disease initiative ...

Research on fungus spread could help growers predict, monitor and control powdery mildew disease affecting blueberries.

Snow is falling over the Capital Region on Friday morning, slowing down traffic.Last night, snow fell in several places in Jutland, causing traffic problems that blocked roads for short or long ...

A young man in the suburb of Hvidovre was the victim of a murder shortly before midnight on Friday night, according to the police and Ritzau.The man has not yet been identified, but he is a suspect in ...

The deal expands a deal to discover and develop treatments for obesity, type 2 diabetes and cardiovascular disease using ...

Novo Nordisk is doubling down on its collaboration with Valo Health, committing up to $190 million in near-term payments—and ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Scope of collaboration originally signed in 2023 will significantly expand to enable the discovery and development of up to 20 novel drug ...

Novo Nordisk also boasted a 55.6% share of the GLP-1 drug space, compared to 54.4% as of August 2023. The company's most famous brands, Wegovy and Ozempic, are both GLP-1s.

Novo Nordisk has expanded its partnership with Valo Health to advance new therapies for type 2 diabetes, obesity and ...